Skip to main content

and
  1. No Access

    Article

    Fragile sites are preferential targets for integrations of MLV vectors in gene therapy

    Following gene therapy of SCID-X1 using murine leukemia virus (MLV) derived vector, two patients developed leukemia owing to an activating vector integration near the LMO2 gene. We found that these integrations r...

    A C Bester, M Schwartz, M Schmidt, A Garrigue, S Hacein-Bey-Abina in Gene Therapy (2006)

  2. Article

    Erratum: Fragile sites are preferential targets for integrations of MLV vectors in gene therapy

    Correction to: Gene Therapy (2006) 13, 1057–1059. doi:10.1038/sj.gt.3302752 Since the above publication the authors have noticed an error in the first DNA marker of FRA11E in Supplementary Table 1S. The correc...

    A C Bester, M Schwartz, M Schmidt, A Garrigue, S Hacein-Bey-Abina in Gene Therapy (2007)

  3. Article

    Open Access

    Mutation spectrum of Joubert syndrome and related disorders among Arabs

    Joubert syndrome (JS) is a rare autosomal recessive (AR), neurological condition characterized by dysgenesis of the cerebellar vermis with the radiological hallmark of molar tooth sign, oculomotor apraxia, rec...

    Salma Ben-Salem, Aisha M Al-Shamsi, Joseph G Gleeson in Human Genome Variation (2014)

  4. Article

    Erratum: Mutation spectrum of Joubert syndrome and related disorders among Arabs

    Correction to: Human Genome Variation (2014) 1, 14020; doi:10.1038/hgv.2014.20; published online 6 November 2014 After online publication of this review, the authors noticed couple of errors in Table 2 in the ...

    Salma Ben-Salem, Aisha M Al-Shamsi, Joseph G Gleeson in Human Genome Variation (2015)

  5. No Access

    Article

    Co-expression of fibulin-5 and VEGF165 increases long-term patency of synthetic vascular grafts seeded with autologous endothelial cells

    Small caliber synthetic vascular grafts are commonly used for bypass surgery and dialysis access sites but have high failure rates because of neointima formation and thrombosis. Seeding synthetic grafts with e...

    M Preis, J Schneiderman, B Koren, Y Ben-Yosef, D Levin-Ashkenazi, S Shapiro in Gene Therapy (2016)

  6. Article

    Open Access

    Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer

    Pancreatic neuroendocrine tumors (pNETs) are uncommon cancers arising from pancreatic islet cells. Here we report the analysis of gene mutation, copy number, and RNA expression of 57 sporadic well-differentiat...

    Ben Lawrence, Cherie Blenkiron, Kate Parker, Peter Tsai in npj Genomic Medicine (2018)

  7. No Access

    Article

    Adenovirus vector-mediated YKL-40 shRNA attenuates eosinophil airway inflammation in a murine asthmatic model

    Recent studies have revealed that YKL-40 is involved in the pathogenesis of asthma. However, its specific mechanism remains unclear. The present study aims to investigate the effect of adenovirus vector-mediat...

    Ling Wang, Aihua Bao, Ying Zheng, Aying Ma, Yi Wu, Huanxia Shang in Gene Therapy (2021)

  8. Article

    Open Access

    Multiomics characteristics of neurogenesis-related gene are dysregulated in tumor immune microenvironment

    The success of immunotherapy was overshadowed by its low response rate, and the hot or cold tumor microenvironment was reported to be responsible for it. However, due to the lack of an appropriate method, it i...

    Ben Wang, Hai Mou, Mengmeng Liu, Zhujie Ran, **n Li, Jie Li in npj Genomic Medicine (2021)

  9. Article

    Open Access

    Broadening INPP5E phenotypic spectrum: detection of rare variants in syndromic and non-syndromic IRD

    Pathogenic variants in INPP5E cause Joubert syndrome (JBTS), a ciliopathy with retinal involvement. However, despite sporadic cases in large cohort sequencing studies, a clear association with non-syndromic inher...

    Riccardo Sangermano, Iris Deitch, Virginie G. Peter, Rola Ba-Abbad in npj Genomic Medicine (2021)

  10. Article

    Open Access

    Gene therapy for spinal muscular atrophy: the Qatari experience

    Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder characterized by hypotonia, progressive muscle weakness, and wasting. Onasemnogene abeparvovec (Zolgensma®) is a novel gene therapy m...

    Hossamaldein Gaber Ali, Khalid Ibrahim, Mahmoud Fawzi Elsaid in Gene Therapy (2021)

  11. Article

    Open Access

    Whole genome sequencing and in vitro splice assays reveal genetic causes for inherited retinal diseases

    Inherited retinal diseases (IRDs) are a major cause of visual impairment. These clinically heterogeneous disorders are caused by pathogenic variants in more than 270 genes. As 30–40% of cases remain geneticall...

    Zeinab Fadaie, Laura Whelan, Tamar Ben-Yosef, Adrian Dockery in npj Genomic Medicine (2021)

  12. Article

    Open Access

    Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer

    Fragmentation patterns of plasma cell-free DNA (cfDNA) are known to reflect nucleosome positions of cell types contributing to cfDNA. Based on cfDNA fragmentation patterns, the deviation in nucleosome footprin...

    Adriaan Vanderstichele, Pieter Busschaert, Chiara Landolfo in npj Genomic Medicine (2022)

  13. Article

    Open Access

    DNA and RNA base editors can correct the majority of pathogenic single nucleotide variants

    The majority of human genetic diseases are caused by single nucleotide variants (SNVs) in the genome sequence. Excitingly, new genomic techniques known as base editing have opened efficient pathways to correct...

    Ariel Dadush, Rona Merdler-Rabinowicz, David Gorelik, Ariel Feiglin in npj Genomic Medicine (2024)